SCHEMBL9610845

SCHEMBL9610845

CCc1ccc(NC(=O)C(F)(F)C(F)(F)C(F)(F)C(=O)O)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 10/20 0.51
HDAC7 Q8WUI4 10/20 0.51
HDAC8 Q9BY41 10/20 0.51
HDAC6 Q9UBN7 9/20 0.51
HDAC3 O15379 3/20 0.51
HDAC4 P56524 3/20 0.51
HDAC2 Q92769 3/20 0.51
HDAC10 Q969S8 3/20 0.51
HDAC11 Q96DB2 3/20 0.51
HDAC9 Q9UKV0 3/20 0.51
HDAC5 Q9UQL6 3/20 0.51
SRC P12931 1/20 0.46
RAB9A P51151 2/20 0.45
CRHBP P24387 1/20 0.43
CRHR2 Q13324 1/20 0.43
ALDH1A1 P00352 1/20 0.43
NPC1 O15118 1/20 0.43
TP53 P04637 1/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9610847 0.91 SRC (0.49) HDAC1HDAC7HDAC8HDAC6HDAC3
SCHEMBL9791549 0.86 CA1 (0.57) HDAC1HDAC7HDAC8HDAC6HDAC3
SCHEMBL30249175 0.81 HDAC1 (0.53) HDAC1HDAC7HDAC8HDAC6HDAC3
SCHEMBL30249298 0.80 HDAC1 (0.70) HDAC1HDAC7HDAC8HDAC6HDAC3
SCHEMBL17845228 0.80 EPHX2 (0.55) HDAC1HDAC7HDAC8HDAC6HDAC3
SCHEMBL9610848 0.79 DGAT1 (0.46) HDAC1HDAC7HDAC8HDAC6HDAC3
SCHEMBL20870490 0.78 SRC (0.51) HDAC1HDAC7HDAC8HDAC6HDAC3
SCHEMBL13661999 0.75 L3MBTL1 (0.73) HDAC1HDAC7HDAC8HDAC6HDAC3
SCHEMBL2023219 0.74 SRC (0.63) HDAC1HDAC7HDAC8HDAC6HDAC3
SCHEMBL6929655 0.74 KMT2A (0.56) HDAC1HDAC7HDAC8HDAC6HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651411-B1 METHODS AND COMPOSITIONS FOR IMPROVED F-18 LABELING OF PROTEINS, PEPTIDES AND OTHER MOLECULES IMMUNOMEDICS INC (US) 2020-09-16 EP disclosed
US-9399077-B2 Metallocene compounds and labeled molecules comprising the same for in vivo imaging APTENIA S.R.L. (IT) 2016-07-26 US disclosed
US-9399077-B2 Metallocene compounds and labeled molecules comprising the same for in vivo imaging APTENIA S.R.L. (IT) 2016-07-26 US disclosed
US-20160008495-A1 Metallocene Compounds and Labeled Molecules Comprising the Same for In Vivo Imaging APTENIA S.R.L. (IT) 2016-01-14 US disclosed
US-20160008495-A1 Metallocene Compounds and Labeled Molecules Comprising the Same for In Vivo Imaging APTENIA S.R.L. (IT) 2016-01-14 US disclosed
US-9028800-B2 Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules IMMUNOMEDICS, INC. (US) 2015-05-12 US disclosed
US-9028800-B2 Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules IMMUNOMEDICS, INC. (US) 2015-05-12 US disclosed
US-20140377177-A1 Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules IMMUNOMEDICS, INC. 2014-12-25 US disclosed
US-20140377177-A1 Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules IMMUNOMEDICS, INC. 2014-12-25 US disclosed
US-8758726-B2 Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules IMMUNOMEDICS, INC. (US) 2014-06-24 US disclosed
US-8758726-B2 Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules IMMUNOMEDICS, INC. (US) 2014-06-24 US disclosed
US-20140017168-A1 Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules IMMUNOMEDICS, INC. (US) 2014-01-16 US disclosed
US-20140017168-A1 Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules IMMUNOMEDICS, INC. (US) 2014-01-16 US disclosed
US-8545809-B2 Methods and compositions for improved 18F labeling of proteins, peptides and other molecules IMMUNOMEDICS, INC. (US) 2013-10-01 US disclosed
US-8545809-B2 Methods and compositions for improved 18F labeling of proteins, peptides and other molecules IMMUNOMEDICS, INC. (US) 2013-10-01 US disclosed
WO-2012082618-A2 METHODS AND COMPOSITIONS FOR IMPROVED F-18 LABELING OF PROTEINS, PEPTIDES AND OTHER MOLECULES IMMUNOMEDICS, INC. (US) 2012-06-21 WO disclosed
US-20120134920-A1 Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules IMMUNOMEDICS, INC. (US) 2012-05-31 US disclosed
US-20120134920-A1 Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules IMMUNOMEDICS, INC. (US) 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120134920-A1 Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules F13B, FCGRT, PAICS HDAC1 4059/4885HDAC7 4762/4885HDAC8 3925/4885
US-20160008495-A1 Metallocene Compounds and Labeled Molecules Comprising the Same for In Vivo Imaging MEN1, MPI, TFRC HDAC1 2248/4885HDAC7 4351/4885HDAC8 4567/4885
US-20140017168-A1 Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules F13B, FCGRT, PAICS HDAC1 4059/4885HDAC7 4762/4885HDAC8 3925/4885
US-20140377177-A1 Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules F13B, FCGRT, PAICS HDAC1 4059/4885HDAC7 4762/4885HDAC8 3925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.